Skip to main content

Table 4 Univariate analyses comparing survival in patient groups stratified by treatment-related characteristics

From: Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer

Characteristic

Hazard ratio

95%CI

P-value

Endocrine Therapy

   

 No

1.00

reference

<0.0001

 Any

0.60

0.47 – 0.77

 

SERM

   

 No

1.00

reference

0.007

 Yes

0.63

0.48 – 0.82

 

AI

   

 No

1.00

reference

<.0001

 Yes

0.47

0.34 – 0.66

 

LHRH

   

 No

1.00

reference

0.75

 Yes

0.85

0.31 – 2.30

 

Fulvestrant

   

 No

1.00

reference

0.0004

 Yes

0.29

0.15 – 0.57

 

Chemotherapy

   

 No

1.00

reference

0.06

 Yes

0.76

0.57 – 1.02

 

Category

   

 A

1.00

reference

 

 A+B

0.8

0.60 – 1.07

0.13

HER2-Directed Therapy

   

 No

1.00

reference

0.15

 Yes

0.69

0.41 – 1.14

 

Bisphosphonate Therapy

   

 No

1.00

reference

0.02

 Yes

0.70

0.52 – 0.96

 

Pamidronic acid

   

 No

1.00

reference

0.44

 Yes

0.87

0.62 – 1.23

 

Zoledronic acid

   

 No

1.00

reference

0.002

 Yes

0.50

0.32 – 0.77

Â